神经刺激设备市场规模、份额和成长分析：按类型、应用和地区划分 - 产业预测，2024-2031 年

预计2022年全球神经刺激设备市场规模为53亿美元，从2023年的59.8亿美元成长到2031年的156.7亿美元，复合年增长率预计将成长12.80%。

神经刺激是一种使用植入式医疗设备来调节和改变神经活动的治疗技术。此过程中使用的设备称为神经刺激装置，治疗过程包括向大脑、週边神经系统和脊髓的目标区域发送电脉衝。神经刺激对于治疗帕金森氏症、癫痫、慢性疼痛和忧郁症神经系统疾病特别有效。对于患有帕金森氏症和肌张力不全症疾病的患者，其症状可能因长期压力或社会限製而加剧，电刺激可以缓解症状并提高生活品质。由于人口老化、先进技术的市场开拓、辅助性治疗的使用增加以及偏头痛和癫痫等慢性疾病的盛行率上升等因素，神经刺激设备的市场正在扩大。此外，大量未满足的医疗需求、神经系统疾病负担的增加、外部研究资金的获取以及对微创手术的偏好正在推动市场成长。例如，中风和阿兹海默症是美国的主要原因，而帕金森氏症影响近100万美国，每年新增病例超过6万例。随着这些疾病发病率的增加，对神经刺激设备的需求也预计会增加。製造商正在投资研究来推进这些技术，目标是提供侵入性较小的产品，从而缩短住院时间并加快康復时间。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场成功因素
• 竞争程度
• 主要投资机会
• 市场魅力指数
• 生态系绘图
• 技术分析
• 成本分析
• 市场趋势分析
• 竞品分析
• 供应链分析
• 投资分析
• 针对特定应用的分析
• 专利分析
• 贸易分析
• 案例研究分析
• 波特五力分析

神经刺激设备市场：按类型

• 市场概况
• 内部神经调节
  • 脊髓刺激
  • 脑深部刺激
  • 迷走神经刺激
  • 荐椎神经刺激
  • 胃电刺激
• 外部神经调节
  • 经皮神经电刺激 (TENS)
  • 经颅磁刺激（TMS）
  • 呼吸电刺激 (RES)

神经刺激设备市场：依应用分类

• 市场概况
• 脊髓刺激
  • 故障恢復综合症
  • 慢性疼痛
  • 缺血
• 脑深部刺激
  • 帕金森氏症
  • 震颤
  • 忧郁症
  • 其他的
• 荐椎神经刺激
  • 尿失禁
  • 大便失禁
• 迷走神经刺激
  • 癫痫
  • 其他的
• 胃电刺激
  • 胃轻瘫
  • 肥胖
• 经皮神经电刺激
  • 抗治疗性忧郁症
  • 其他的
• 经颅磁刺激
  • 忧郁症
  • 偏头痛
• 呼吸电刺激
  • 脊髓损伤

神经刺激设备市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic（Ireland）
• Abbott Laboratories（US）
• Boston Scientific Corporation（US）
• LivaNova PLC（UK）
• Nevro Corp.（US）
• NeuroPace, Inc.（US）
• Synapse Biomedical Inc.（US）
• Neuronetics, Inc.（US）
• NDI Medical LLC（US）
• Stimwave Technologies（US）
• BioControl Medical（Israel）
• EndoStim（US）
• Aleva Neurotherapeutics（Switzerland）
• SPR Therapeutics（US）
• electroCore, Inc.（US）
• Soterix Medical Inc.（US）
• Cala Health（US）
• Inspire Medical Systems, Inc.（US）
• NeuroSigma, Inc.（US）
• Autonomic Technologies Inc.（US）
• Axonics Modulation Technologies, Inc.（US）
• Nexstim Plc（Finland）

Global Neurostimulation Devices Market size was valued at USD 5.3 Billion in 2022 and is poised to grow from USD 5.98 Billion in 2023 to USD 15.67 Billion by 2031, at a CAGR of 12.80% during the forecast period (2024-2031).

Neurostimulation is a therapeutic technique that utilizes implantable medical devices to regulate and alter neural activity. The devices employed in this process are known as neurostimulators, and the therapy involves delivering electrical impulses to targeted regions of the brain, peripheral nervous system, or spinal cord. Neurostimulation is particularly effective in managing neurological disorders like Parkinson's disease, epilepsy, chronic pain, and depression. It works by providing electrical stimulation that can help alleviate symptoms and enhance the quality of life for patients with conditions such as Parkinson's disease or dystonia, who may experience worsened symptoms due to chronic stress and social restrictions. The market for neurostimulation devices is expanding due to several factors, including an aging population, the development of advanced technologies, increasing use as adjunctive therapy, and the rising prevalence of chronic conditions like migraines and epilepsy. Additionally, high unmet medical needs, the growing burden of neurological disorders, external research funding, and a preference for minimally invasive procedures are driving market growth. For instance, stroke and Alzheimer's disease are major causes of death in the U.S., with Parkinson's disease affecting nearly one million Americans and over 60,000 new cases annually. As the incidence of these diseases rises, the demand for neurostimulation devices is projected to grow. Manufacturers are investing in research to advance these technologies, aiming to offer products that are less invasive, leading to shorter hospital stays and quicker recovery times, which will further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurostimulation Devices Market Segmental Analysis

The Global Neurostimulation Devices market is segmented by type, Application, and region. Based on type, the market can be segmented into Internal Neuromosulation (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator) External neuromodulation (Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS), Respiratory Electrical Stimulation (RES)). Based on Application, the market is segmented into Spinal Cord Stimulation (Failed Back Syndrome, Chronic Pain, Ischemia), Deep Brain Stimulation (Parkinson's Disease, Tremor, Depression, Others), Sacral Nerve Stimulation (Urine Incontinence, Fecal Incontinence), Vagus Nerve Stimulation (VNS) (Epilepsy, Others), Gastric Electrical Stimulation (Gastroparesis, Obesity), Transcutaneous Electrical Nerve Stimulation (Treatment-resistant Depression, Others), Transcranial Magnetic Stimulation (Depression, Migraine Headache), Respiratory Electrical Stimulation (Spinal Cord Injury). Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurostimulation Devices Market

A major driver of the neurostimulation devices market is the escalating prevalence of neurological disorders globally. According to the World Health Organization, neurological conditions contribute significantly to the global disease burden, impacting millions of individuals. The rising incidence of disorders such as Parkinson's disease, epilepsy, and chronic pain is increasing the demand for neurostimulation devices, which offer effective treatment solutions. This growing need for advanced therapies is prompting manufacturers to invest heavily in research and development to create innovative neurostimulation devices. Such advancements are anticipated to further drive market expansion.

Restraints in the Global Neurostimulation Devices Market

Despite the increasing demand for neurostimulation devices, several factors are hindering market growth. One major restraint is the high cost of these devices, which poses a significant financial burden on patients, particularly in low- and middle-income countries. Additionally, the shortage of skilled healthcare professionals and the limited availability of neurostimulation devices in certain regions further restrict market expansion. Moreover, potential risks related to device implantation, such as infections and device malfunctions, also contribute to market challenges.

Market Trends of the Global Neurostimulation Devices Market

A prominent trend in the neurostimulation devices market is the advancement of minimally invasive and non-invasive technologies. These innovations are increasingly favored due to their benefits over traditional surgical methods, such as reduced pain, shorter hospital stays, and quicker recovery periods. Additionally, the emergence of wireless and implantable devices is contributing to market growth, as they enhance patient comfort by eliminating the need for external wires and bulky equipment. This shift towards less invasive neurostimulation solutions is anticipated to drive continued market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors of The Market
• Degree Of Competition
• Top Investment Pockets
• Market Attractive Index
• Ecosystem Mapping
• Technology Analysis
• Cost Analysis
• Market Trend Analysis
• Competition Analysis
• Supply chain analysis
• Investment Analysis
• Application-Specific Analysis
• Patent analysis
• Trade analysis
• Case study analysis
• Porter's five forces analysis

Global Neurostimulation Devices Market by Type

• Market overview
• Internal Neuromodulation
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
• External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transcranial Magnetic Stimulation (TMS)
  • Respiratory Electrical Stimulation (RES)

Global Neurostimulation Devices Market by Application

• Market Overview
• Spinal Cord Stimulation Market
  • Failed Back Syndrome
  • Chronic Pain
  • Ischemia
• Deep Brain Stimulation Market
  • Parkinson's Disease
  • Tremor
  • Depression
  • Other DBS Applications
• Sacral Nerve Stimulation Market
  • Urine Incontinence
  • Fecal Incontinence
• Vagus Nerve Stimulation Market
  • Epilepsy
  • Other VNS Applications
• Gastric Electrical Stimulation Market
  • Gastroparesis
  • Obesity
• Transcutaneous Electrical Nerve Stimulation Market
  • Treatment-resistant Depression
  • Other TENS Applications
• Transcranial Magnetic Stimulation Market
  • Depression
  • Migraine Headache
• Respiratory Electrical Stimulation Market
  • Spinal Cord Injury

Global Neurostimulation Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NDI Medical LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoStim (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• electroCore, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cala Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autonomic Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics Modulation Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments